MAPT and Alzheimer disease: Clinical and preclinical studies showed that anesthetic agents stimulate/initiate neuropathogenesis of Alzheimer’s disease (AD) by inducing hyper-phosphorylation of tau protein followed by deposition of β‐amyloid proteins [18–20].